N-Phenyl-7-(hydroxyimino)cyclopropa[b]chromen-1a-carboxamide (PHCCC) was the first modulator selective for group III receptors, specifically mGlu4R. Interestingly, this compound was first described in 1996 by Annoura and colleagues as a mGlu1R antagonist [140]. In 2003, the other authors demo...